Today, Amgen shared its 2024 fourth quarter and full year earnings report. Amgen’s more than 27,000 employees are united by our mission to serve patients. We harness the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller, and longer.
"Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong performance globally, we are investing heavily in our rapidly advancing pipeline to deliver innovative therapies across our four therapeutic areas," said Bob Bradway, Chairman and Chief Executive Officer, Amgen.
The infographic below provides more highlights about the company’s 2024 full year results.
Additional details can be found in the earnings press release. Please see forward-looking statements.
A webcast of the earnings call found on Amgen’s Investors page.
